2022
Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy
Tuan J, Kayani J, Fisher A, Kotansky B, Dembry L, Datta R. Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy. Antimicrobial Stewardship & Healthcare Epidemiology 2022, 2: e83. PMID: 36483361, PMCID: PMC9726471, DOI: 10.1017/ash.2022.229.Peer-Reviewed Original ResearchDalbavancin administrationOutpatient parenteral antimicrobial therapyDose of dalbavancinMedian antibiotic durationSoft tissue infectionsParenteral antimicrobial therapyAntibiotic durationDeveloped hepatotoxicityClinical cureSeptic arthritisClinical outcomesAntimicrobial therapyPatientsAdministrationDaysEndocarditisArthritisBacteremiaOsteomyelitisHepatotoxicityTherapyDalbavancinInfectionDose
2013
Validation of the surveillance and reporting of central line-associated bloodstream infection denominator data
Backman LA, Nobert G, Melchreit R, Fekieta R, Dembry LM. Validation of the surveillance and reporting of central line-associated bloodstream infection denominator data. American Journal Of Infection Control 2013, 42: 28-33. PMID: 24176605, DOI: 10.1016/j.ajic.2013.06.014.Peer-Reviewed Original ResearchConceptsDenominator dataBlinded retrospective chart reviewCentral line-associated infectionsLine-associated infectionsRetrospective chart reviewAcute care hospitalsNational surveillance systemComparison of hospitalSignificant differencesChart reviewCare hospitalPatient chartsHospitalInternal validationConnecticut DepartmentPublic healthSurveillance systemCountCLDStrict definitionDaysReportingInfection
1996
Control of endemic glycopeptide-resistant enterococci.
Dembry LM, Uzokwe K, Zervos MJ. Control of endemic glycopeptide-resistant enterococci. Infection Control And Hospital Epidemiology 1996, 17: 286-92. PMID: 8727617, DOI: 10.1086/647297.Peer-Reviewed Original ResearchConceptsVancomycin-resistant EnterococcusRenal unitsEradication of carriageVRE stool colonizationCommunity teaching hospitalPatient carriageBarrier precautionsOral doxycyclineFurther patientsStool colonizationGlycopeptide-resistant enterococciCulture surveyTeaching hospitalPatientsStudy periodEnterococcus faeciumEnterococcus gallinarumCarriageRifampinDoxycyclineEnterococcusControl measuresDaysUseful measureHospitalControl of Endemic Glycopeptide-Resistant Enterococci
Dembry L, Uzokwe K, Zervos M. Control of Endemic Glycopeptide-Resistant Enterococci. Infection Control And Hospital Epidemiology 1996, 17: 286-292. DOI: 10.2307/30141928.Peer-Reviewed Original ResearchVancomycin-resistant EnterococcusRenal unitsEradication of carriageVRE stool colonizationCommunity teaching hospitalPatient carriageBarrier precautionsOral doxycyclineFurther patientsStool colonizationGlycopeptide-resistant enterococciCulture surveyTeaching hospitalPatientsStudy periodEnterococcus faeciumEnterococcus gallinarumEnterococcus faecalisCarriageRifampinDoxycyclineEnterococcusControl measuresDaysUseful measure